NCT07096921 - The Effect of Two Prokinetics in Patients With Functional Dyspepsia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 8, 2025

Primary Completion Date

March 19, 2026

Study Completion Date

March 19, 2026

Conditions

Functional Dyspepsia

Interventions

DRUG

Mosapride citrate 5 mg + DA-9701 30 mg

Experimental: Mosapride citrate 5 mg + DA-9701 30 mg, Oral, 3 times/day, 30 min before meals for 4 weeks

DRUG

Mosapride citrate 5 mg + DA-9701 30 mg placebo

Placebo Comparator: Mosapride citrate 5 mg + DA-9701 placebo, Oral, 3 times/day, 30 min before meals for 4 weeks

Trial Locations (1)

The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul